EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Catastrophic health expenditures and economic burden of end-stage kidney disease among patients receiving hemodialysis or conservative care in Lao PDR

Mick Soukavong, Manit Sittimart iD, Thidachanh Soukhasem, Somvai Singhaxaiyaseng, Chanmaly Keomany, Oulai Oudommixay, Sysavanh Phommachanh, Elizabeth A Ashley, Yot Teerawattananon, Mayfong MayxaY

PLOS Global Public Health · 05.11.2026 · 6 (11) · e0007532

DOI: 10.1371/journal.pgph.0007532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Global Public Health, online erschienen am 05.11.2026. Verfasst von Mick Soukavong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unit for Health Evidence and Policy (UHEP), Institute of Research and Education Development, University of Health Sciences, Ministry of Health, Vient…. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Strengthening Active Partnerships for Policy and Health Intervention Research and Evaluation (SAPPHIRE) consortium, Wellcome Trust, The National Science, Research and Innovation Fund (NSRF) via the Program Management Unit for Human Resources & Institutional Development, Research and Innovat….

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Lao PDR, limited health insurance coverage poses significant challenges for patients requiring renal replacement therapy (RRT). However, the economic burden of end-stage kidney disease (ESKD), particularly for patients receiving hemodialysis compared with conservative care, remains poorly documented. We conducted a cross-sectional, prevalence-based, costing study, using consecutive sampling of ESKD patients receiving hemodialysis or conservative care at two tertiary hospitals in Lao PDR in 2025. A total of 117 patients were enrolled. Direct medical, direct non-medical, and caregiver productivity costs were collected through hospital surveys and patient interviews and annualized. National economic burden was extrapolated using estimated ESKD prevalence and assumed treatment distribution. The projected annual economic burden was estimated at 2.1 trillion kip (≈USD105 million) in 2025, based on an expert-informed treatment distribution used for national extrapolation. On average, this was approximately 280 million Kip/patient (≈USD13,692), largely driven by medical expenses. The average annual economic cost, comprised of medical, non-medical, and productivity costs, was 332 million Kip/year for hemodialysis patients, exceeding their average annual income (62 million Kip) by more than fivefold. Using 40% of total household income as an unadjusted proxy for capacity-to-pay, 83% of hemodialysis households and 63% of conservative care households exceeded the threshold, despite limited formal financial protection. Caregivers also experienced financial burdens through income loss and additional expenditures. Conservative care patients, though incurring lower costs, tended to be from economically vulnerable populations. ESKD imposes a considerable economic burden on patients and households in Lao PDR, particularly for those receiving hemodialysis in a setting with limited financial protection. These findings suggest that expanding health insurance coverage for ESKD patients and subsidizing non-medical costs are urgently needed.

Autor:innen und Institutionen

  • Unit for Health Evidence and Policy (UHEP), Institute of Research and Education Development, University of Health Sciences, Ministry of Health, Vientiane, Lao PDR.
  • Department of Natural and Social Sciences, Faculty of Medicine, University of Health Sciences, Vientiane, Lao PDR.
  • Health Intervention and Technology Assessment Program Foundation (HITAP), Nonthaburi, Thailand.
  • Department of Nephrology, Mittaphab Hospital, Vientiane, Lao PDR.
  • Microbiology Laboratory, Lao-Oxford Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Mahosot Hospital, Vientiane, Lao PDR.
  • Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom.

ORCID-Profile: Manit Sittimart

Förderung

  • the Strengthening Active Partnerships for Policy and Health Intervention Research and Evaluation (SAPPHIRE) consortium
  • Wellcome Trust
  • The National Science, Research and Innovation Fund (NSRF) via the Program Management Unit for Human Resources & Institutional Development, Research and Innovat…

Zitieren

APA

Soukavong, M., Sittimart, M., Soukhasem, T., Singhaxaiyaseng, S., Keomany, C., Oudommixay, O., Phommachanh, S., Ashley, E. A., Teerawattananon, Y., & MayxaY, M. (2026). Catastrophic health expenditures and economic burden of end-stage kidney disease among patients receiving hemodialysis or conservative care in Lao PDR. PLOS Global Public Health, 6(11), e0007532. https://doi.org/10.1371/journal.pgph.0007532

Vancouver

Soukavong M, Sittimart M, Soukhasem T, Singhaxaiyaseng S, Keomany C, Oudommixay O, et al. Catastrophic health expenditures and economic burden of end-stage kidney disease among patients receiving hemodialysis or conservative care in Lao PDR. PLOS Global Public Health. 2026;6(11):e0007532. doi:10.1371/journal.pgph.0007532

BibTeX
@article{Soukavong2026,
  author = {Soukavong, Mick and Sittimart, Manit and Soukhasem, Thidachanh and Singhaxaiyaseng, Somvai and Keomany, Chanmaly and Oudommixay, Oulai and Phommachanh, Sysavanh and Ashley, Elizabeth A and Teerawattananon, Yot and MayxaY, Mayfong},
  title = {Catastrophic health expenditures and economic burden of end-stage kidney disease among patients receiving hemodialysis or conservative care in Lao PDR},
  journal = {PLOS Global Public Health},
  year = {2026},
  volume = {6},
  number = {11},
  pages = {e0007532},
  doi = {10.1371/journal.pgph.0007532}
}
Kostenlos starten →